HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ulta 3Q

This article was originally published in The Rose Sheet

Executive Summary

Beauty retailer recorded a 69% jump in profit in the third quarter (ended Oct. 31) to $8.46 mil. Quarterly sales increased 11.5% to $284 million. For the nine-month period, net sales advanced 11.2% to $826.4 million while net income grew 47% to $19.1 million. President and CEO Lyn Kirby says Ulta is well-positioned heading into the fourth quarter. "Because we expect the holiday season to be challenging, we have developed a very dynamic marketing and merchandising program with several new and exciting first-ever strategies to drive the top line," she states in a recent release. The firm plans to open 37 new stores and cut expenses by $18 mil. in the fourth quarter

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016629

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel